5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Aarti Pharmalabs Ltd.

•
aartipharmalabs.comBSE: 543748NSE: AARTIPHARM
Market Cap₹ 7,516 Cr.
Current Price
High / Low₹ 946 / 585
Stock P/E36.1
Book Value₹ 226
Price to Book2.70
Dividend Yield0.42 %
ROCE11.5 %
ROE9.2 %
Face Value₹ 5

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Latest quarter profit grew 39.2% YoY, showing strong momentum
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.23x)
  • Working capital cycle has improved - days down from 122 to 95
  • Company maintains a comfortable, low leverage position

CONS

  • Recent results are weak - TTM profit is down 24.6% versus prior year
  • Promoter holding has decreased over last 2 years: -3.6pp
  • Free cash flow has been persistently negative
  • Total debt has risen sharply - up 73.6% year on year

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY MICROCAP250NIFTY TOTAL MKT
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.AARTIPHARM828.8535.267516.000.4276.1453.82535.8038.7410.7726.78
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
358356373415393377471530375417425580535
281282285307310293356389280343322463441
Operating Profit7774881078485115141957410311793
OPM %21.43%20.72%23.66%25.88%21.26%22.47%24.42%26.56%25.35%17.73%24.21%20.19%17.45%
50062312-023-3113
Interest444445106711131713
Depreciation15161717181921212325292830
Profit before Tax625467916363961146742598396
Tax %23.34%22.10%28.54%30.96%25.43%24.59%23.56%21.73%23.75%25.83%25.16%24.89%25.90%
Net Profit48424863474874895131446271
5.264.615.326.955.205.288.119.805.653.414.846.847.87

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
009411,5111,5021,7711,7981,957
007611,2031,1561,3451,4251,570
Operating Profit-0-0180308346427373387
OPM %——19.11%20.40%23.04%24.08%20.75%19.79%
003111141313
Interest00112017264753
Depreciation0037566679104112
Profit before Tax-0-0134233275336234279
Tax %-0.00%-0.00%20.19%26.41%26.91%23.49%24.78%25.44%
Net Profit-0-0107172201257176208
EPS-0.75-0.1811.7818.9522.1428.3919.44—
Dividend Payout %0.00%0.00%0.00%10.55%13.55%17.61%18.01%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
—
3 Years:
6%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
1%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
25%
1 Year:
-9%

RETURN ON EQUITY

10 Years:
—
5 Years:
13%
3 Years:
12%
Last Year:
9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Sep 15

₹ 0.40

Rs.2.0000 per share(40%)Final Dividend

2026

Feb 16

₹ 0.30

Rs.1.5000 per share(30%)Interim Dividend

2025

Sep 15

₹ 0.50

Rs.2.5000 per share(50%)Final Dividend

2025

Feb 14

₹ 0.50

Rs.2.5000 per share(50%)Interim Dividend

2024

Jul 31

₹ 0.20

Rs.1.0000 per share(20%)Final Dividend

2024

Feb 16

₹ 0.40

Rs.2.0000 per share(40%)Interim Dividend

2023

Jan 17

₹ 0.40

2026

Aug 18

₹ 0.40

20/10/2026 Equity Rs.2.0000 per share(40%)Final Dividend

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital045454545
1,2391,3931,5761,7971,934
326207267422734
Trade Payables132212255249324
130118153207290
Total Liabilities1,8271,9762,2972,7203,328
7018489531,0591,437
Capital Work in Progress1656278301305
4055625744
444538582544636
00449553587
Cash & Bank560447
420472168202312
Total Assets1,8271,9762,2972,7203,328

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
-00-50273184339257
Cash from Investing00-134-116-184-418-425
Cash from Financing00255-157479171
0056-564-13

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
46.4646.1044.6644.2943.7242.8843.1043.0842.86
7.077.388.647.367.348.027.688.398.17
11.4611.3510.367.527.806.957.667.407.21
0.010.010.010.010.010.010.010.010.01
35.0035.1636.3340.8241.1242.1341.5441.1141.75

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-02
General Updates

2026-09-02 - Aarti Pharmalabs Limited has informed the Exchange about General Updates

2026-08-31
Resignation of Director/KMP/SMP

2026-08-31 - Aarti Pharmalabs Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-31
Change in Management

2026-08-31 - Aarti Pharmalabs Limited has informed the Exchange about change in Management

2026-08-30
Copy of Newspaper Publication

2026-08-30 - Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-29
Updates

2026-08-29 - Aarti Pharmalabs Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2025-26'.

2026-08-29
Shareholders meeting

2026-08-29 - Aarti Pharmalabs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2026

2026-08-18
Copy of Newspaper Publication

2026-08-18 - Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-17
Record Date

2026-08-17 - Aarti Pharmalabs Limited has informed the Exchange that Record date for the purpose of Dividend is 15-Sep-2026.

2026-08-17
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Aarti Pharmalabs Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for AARTIPHARM

Loading news…

🤖

AI Stock Analyst

Aarti Pharmalabs Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login